Nanobodies: A new therapeutic approach against Covid-19
COVID-19 Nanobody ACE2 Receptor

Nanobodies: A new therapeutic approach against Covid-19

Santhni Subramaniam
Santhni Subramaniam

In 10 seconds? The Covid-19 pandemic has seen various vaccines rolled out across the globe. However, their effectiveness varies against new viral strains. Emerging ‘nanobody’ therapies can offer a prophylactic option but they will take years to authorise.

This post is for members only

Subscribe
Already have an account? Sign in

Try Sparrow today

  • Read the latest science updates in just three minutes
  • Get five Digests emailed to you every week—100% free
  • No angle. No agenda. Just the facts.
  • Premium subscribers get access to the complete Sparrow library